Pharma-Bio Serv (OTCMKTS:PBSV) Shares Cross Below 200-Day Moving Average – Should You Sell?

Shares of Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.56 and traded as low as $0.42. Pharma-Bio Serv shares last traded at $0.43, with a volume of 8,200 shares traded.

Pharma-Bio Serv Trading Up 2.4 %

The company has a fifty day moving average price of $0.54 and a two-hundred day moving average price of $0.56. The company has a market cap of $9.86 million, a price-to-earnings ratio of -14.33 and a beta of 0.53.

Pharma-Bio Serv (OTCMKTS:PBSV) last posted its earnings results on Monday, March 17th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.02 by $0.35. The business had revenue of $2.47 million during the quarter, compared to the consensus estimate of $2.70 million. Pharma-Bio Serv had a negative return on equity of 5.61% and a negative net margin of 8.18%. Sell-side analysts anticipate that Pharma-Bio Serv, Inc. will post 0.11 EPS for the current fiscal year.

Pharma-Bio Serv Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Thursday, March 20th. Shareholders of record on Friday, February 28th were given a $0.075 dividend. The ex-dividend date was Friday, February 28th. Pharma-Bio Serv’s payout ratio is -375.00%.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.